Great Point Partners LLC Cin Cor Pharma, Inc. Transaction History

Great Point Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.75 - $29.84 $7.72 Million - $21.4 Million	717,829 Added 238.22%	1,019,153 $12.5 Million
Q3 2022 Nov 14, 2022	SELL	$19.9 - $38.94 $7.32 Million - $14.3 Million	-367,876 Reduced 54.97%	301,324 $9.89 Million
Q2 2022 Aug 15, 2022	BUY	$13.67 - $25.74 $8.06 Million - $15.2 Million	589,530 Added 739.96%	669,200 $12.6 Million
Q1 2022 May 16, 2022	BUY	$14.13 - $28.49 $1.13 Million - $2.27 Million	79,670 New	79,670 $1.4 Million

Ticker CINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,764,300
Description
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Great Point Partners LLC with notifications on news.